Zai Lab (ZLAB)

• Market cap: $2.21B
• 1 day: -0.45%
• 5 days: -2.78%
• 1 month: -24.28%
• 3 months: -41.43%
• 6 months: -35.75%
• Year to date: -19.67%
• 1 year: -29.05%
• 5 years: -81.27%
• 10 years: -28.64%
• Sector: Healthcare
• Industry: Biotechnology

About: Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Employees: 1,844